advertisement
11.4 Prostaglandins (14)
Showing records 1 to 14
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins20001 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure
Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
Ophthalmology 2007; 114: 2244-2251
19966 Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial
Koz OG; Ozsoy A; Yarangumeli A; Kose SK; Kural G
Acta Ophthalmologica Scandinavica 2007; 85: 838-843
19964 Effects of topical travoprost and unoprostone on optic nerve head circulation in normal rabbits
Ohashi M; Mayama C; Ishii K; Araie M
Current Eye Research 2007; 32: 743-749
19873 What should we think? Should Diamox and pilocarpine continue to be prescribed?
Sirbat D
Journal Français d'Ophtalmologie 2007; 30: 5 Pt 2 3S72-73
19718 Conjunctival hyperaemia and other ocular adverse effects on healthy African subjects after single dosing with 0.004% Travoprost
Ashaye AO; Adedapo AD; Olusanya BA; Adeoti CO
African Journal of Medicine and Medical Science 2007; 36: 37-42
19708 Bimatoprost, a novel efficacious ocular hypotensive drug now recognized as a member of a new class of agents called prostamides
Burk RM; Woodward DF
Drug Development Research 2007; 147-155
19796 Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients
Chiselita D
Oftalmologia 2007; 51: 81-86
19802 Prostaglandins in the patent literature
Ebenezar KK; Smith FG
Expert Opinion on Therapeutic Patents 2007; 17: 1131-1145
19772 Comparative evaluation of bimatoprost monotherapy in primary chronic angle closure and primary open angle glaucoma eyes: A three-year study
Gupta V; Srinivasan G; Sharma A; Kapoor KS; Sihota R
Journal of Ocular Pharmacology and Therapeutics 2007; 23: 351-358
20119 Efficacy and safety of a systematic switch from latanoprost to travoprost in patients with glaucoma
Kumar RS; Istiantoro VW; Hoh S-T; Ho C-L; Oen FT; Aung T
Journal of Glaucoma 2007; 16: 606-609
19791 Five years retrospective study of latanoprost glaucoma treatment
Zavorkova M; Susicky P
Česka a Slovenska Oftalmologie 2007; 63: 292-298
20077 Effects of latanoprost, timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist on LTC4 release after rat mast cell activation
Laengle UW; Markstein R; Pralet D; Seewald W; Roman D
Clinical and Experimental Ophthalmology 2007; 35: 645-650
19812 Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension
Frenkel REP; Frenkel M; Toler A
BMC Ophthalmology 2007; 7: Article Number: 16
19788 Refill rates and budget impact of glaucoma lipid therapy: A retrospective database analysis
Walt JG; Wilensky JT; Fiscella R; Chiang TH; Guckian A
Clinical Drug Investigation 2007; 27: 819-825
